Maitreya Medicare last traded at ₹117.00 (2026-10-13). Over the past month the stock moved -3.3%, three months the stock moved -30.6%, year the stock moved -53.8%. Its closing range over 52 weeks is ₹107.75 – ₹286.55, with the latest close 59.2% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]
Business Overview:[1] MML is a Surat-based multi-super speciality hospital with a 125-bed capacity and a 50-bed capacity in its subsidiary, Tulip Health Check. Its facility offers a wide range of integrated healthcare services, spanning primary, secondary, and tertiary care. These include Gastroenterology, Nephrology, General & Laparoscopic Surgery, Urology, Oncology, Oncosurgery, Gynecology and High-Risk Obstetrics, Emergency & Trauma, Cardiology, Orthopedic & Joint Replacement Surgery, Cardiothoracic and Vascular Surgery, Neurology, Critical Care Medicine, Neurosurgery, Spine Surgery, Gastrointestinal Surgery, and Cardiothoracic Surgery, Orthopedic Surgery (Including Joint Replacements and Arthroscopic Surgeries), Hepatocellular Biliary Surgery, etc.
In the latest quarter (Mar 2026), Maitreya Medicare reported sales of ₹21.15 crore (-8.1%) and net profit of ₹-2.43 crore (-2800.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 21.15 | -1.49 | -7.04 | -2.43 | -3.59 |
| Sep 2025 | 23.70 | 1.04 | 4.39 | -0.04 | -0.06 |
| Mar 2025 | 22.30 | 1.70 | 7.62 | 0.15 | 0.22 |
| Sep 2024 | 24.36 | 3.18 | 13.05 | 1.67 | 2.46 |
| Mar 2024 | 23.01 | 1.16 | 5.04 | 0.09 | 0.13 |
| Sep 2023 | 24.79 | 4.56 | 18.39 | 2.56 | 5.16 |
| Sep 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | -4.4% | -8.1% |
| Operating profit growth | -77.2% | -228.4% |
| Net profit growth | -101.6% | -2800.0% |
| EPS growth | -101.2% | -2861.5% |
| OPM % | 4.4% | -7.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Maitreya Medicare reported sales of ₹44.85 crore (-0.3%) and net profit of ₹-2.47 crore (-232.1%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 44.85 | -0.46 | -1.03 | -2.47 | -3.65 |
| Mar 2025 | 44.98 | 4.88 | 10.85 | 1.87 | 2.76 |
| Mar 2024 | 46.08 | 6.00 | 13.02 | 2.97 | 4.38 |
| Mar 2023 | 39.28 | 7.26 | 18.48 | 4.25 | 8.57 |
| Mar 2022 | 49.35 | 3.37 | 6.83 | 1.14 | 1,140.00 |
| Mar 2021 | 55.93 | 7.25 | 12.96 | 4.24 | 4,240.00 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales growth | -11.8% | -20.4% | +17.3% | -2.4% | -0.3% |
| Operating profit growth | -53.5% | +115.4% | -17.4% | -18.7% | -109.4% |
| Net profit growth | -73.1% | +272.8% | -30.1% | -37.0% | -232.1% |
| EPS growth | -73.1% | -99.2% | -48.9% | -37.0% | -232.2% |
| OPM % | 6.8% | 18.5% | 13.0% | 10.9% | -1.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Maitreya Medicare.
Get Free AI Stock Analysis FREE →No recent news available for Maitreya Medicare.
Maitreya Medicare shares were last quoted at ₹117.00 (-1.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Maitreya Medicare has a price-to-earnings (P/E) ratio of -57.51 and a price-to-book (P/B) ratio of 3.13. The industry P/E is 99.89.
The 52-week high of Maitreya Medicare is ₹292.95 and the 52-week low is ₹103.10.
The market capitalisation of Maitreya Medicare is about ₹75.99 crore.
In the latest quarter (Mar 2026), Maitreya Medicare reported sales of ₹21.15 crore (-8.1%) and net profit of ₹-2.43 crore (-2800.0%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Maitreya Medicare has a 3-year ROE of 3.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 73.11% of Maitreya Medicare.
Maitreya Medicare belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z